Dr. David Smith trained at the University of Washington in Seattle, completing a residency in internal medicine in 1988. He completed a fellowship in hematology/oncology at Duke University and then joined the faculty at the University of Pittsburgh and the Pittsburgh Cancer Institute prior to moving to the University of Michigan in 1996. Dr. Smith currently serves as the Clinical Director of the U-M Rogel Cancer Center's Phase I Program. Throughout his career, he has focused on urologic oncology and clinical trials and has published more than 70 peer-reviewed publications in these areas as well as several book chapters. His particular area of interest is in the evaluation of new therapeutics for use in a variety of cancers.
